Linzagolix With and Without Hormonal Add-Back Therapy for the Treatment of Symptomatic Uterine Fibroids: Two Randomized, Placebo-Controlled, Phase 3 Trials

Jacques Donnez; Hugh S. Taylor; Elizabeth A. Stewart; Linda Bradley; Erica Marsh; David Archer; Ayman Al-Hendy; Felice Petraglia; Nelson Watts; Jean Pierre Gotteland; Elke Bestel; Paul Terrill; Ernest Loumaye; Andrew Humberstone; Elizabeth Garner

doi:10.1097/OGX.0000000000001113

Linzagolix With and Without Hormonal Add-Back Therapy for the Treatment of Symptomatic Uterine Fibroids: Two Randomized, Placebo-Controlled, Phase 3 Trials

Jacques Donnez, Hugh S. Taylor, Elizabeth A. Stewart, Linda Bradley, Erica Marsh, David Archer, Ayman Al-Hendy, Felice Petraglia, Nelson Watts, Jean Pierre Gotteland, Elke Bestel, Paul Terrill, Ernest Loumaye, Andrew Humberstone, Elizabeth Garner

Obstetrics/Gynecology

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	741-742
Number of pages	2
Journal	Obstetrical and Gynecological Survey
Volume	77
Issue number	12
DOIs	https://doi.org/10.1097/OGX.0000000000001113
State	Published - Dec 1 2022

ASJC Scopus subject areas

Obstetrics and Gynecology

Access to Document

10.1097/OGX.0000000000001113

Cite this

Donnez, J., Taylor, H. S., Stewart, E. A., Bradley, L., Marsh, E., Archer, D., Al-Hendy, A., Petraglia, F., Watts, N., Gotteland, J. P., Bestel, E., Terrill, P., Loumaye, E., Humberstone, A., & Garner, E. (2022). Linzagolix With and Without Hormonal Add-Back Therapy for the Treatment of Symptomatic Uterine Fibroids: Two Randomized, Placebo-Controlled, Phase 3 Trials. Obstetrical and Gynecological Survey, 77(12), 741-742. https://doi.org/10.1097/OGX.0000000000001113

Linzagolix With and Without Hormonal Add-Back Therapy for the Treatment of Symptomatic Uterine Fibroids: Two Randomized, Placebo-Controlled, Phase 3 Trials. / Donnez, Jacques; Taylor, Hugh S.; Stewart, Elizabeth A. et al.
In: Obstetrical and Gynecological Survey, Vol. 77, No. 12, 01.12.2022, p. 741-742.

Research output: Contribution to journal › Comment/debate › peer-review

Donnez, J, Taylor, HS, Stewart, EA, Bradley, L, Marsh, E, Archer, D, Al-Hendy, A, Petraglia, F, Watts, N, Gotteland, JP, Bestel, E, Terrill, P, Loumaye, E, Humberstone, A & Garner, E 2022, 'Linzagolix With and Without Hormonal Add-Back Therapy for the Treatment of Symptomatic Uterine Fibroids: Two Randomized, Placebo-Controlled, Phase 3 Trials', Obstetrical and Gynecological Survey, vol. 77, no. 12, pp. 741-742. https://doi.org/10.1097/OGX.0000000000001113

@article{fb3f9cee2cd049eeb838af6090800c3b,

title = "Linzagolix With and Without Hormonal Add-Back Therapy for the Treatment of Symptomatic Uterine Fibroids: Two Randomized, Placebo-Controlled, Phase 3 Trials",

author = "Jacques Donnez and Taylor, {Hugh S.} and Stewart, {Elizabeth A.} and Linda Bradley and Erica Marsh and David Archer and Ayman Al-Hendy and Felice Petraglia and Nelson Watts and Gotteland, {Jean Pierre} and Elke Bestel and Paul Terrill and Ernest Loumaye and Andrew Humberstone and Elizabeth Garner",

year = "2022",

month = dec,

day = "1",

doi = "10.1097/OGX.0000000000001113",

language = "English (US)",

volume = "77",

pages = "741--742",

journal = "Obstetrical and Gynecological Survey",

issn = "0029-7828",

publisher = "Lippincott Williams and Wilkins",

number = "12",

}

TY - JOUR

T1 - Linzagolix With and Without Hormonal Add-Back Therapy for the Treatment of Symptomatic Uterine Fibroids

T2 - Two Randomized, Placebo-Controlled, Phase 3 Trials

AU - Donnez, Jacques

AU - Taylor, Hugh S.

AU - Stewart, Elizabeth A.

AU - Bradley, Linda

AU - Marsh, Erica

AU - Archer, David

AU - Al-Hendy, Ayman

AU - Petraglia, Felice

AU - Watts, Nelson

AU - Gotteland, Jean Pierre

AU - Bestel, Elke

AU - Terrill, Paul

AU - Loumaye, Ernest

AU - Humberstone, Andrew

AU - Garner, Elizabeth

PY - 2022/12/1

Y1 - 2022/12/1

UR - http://www.scopus.com/inward/record.url?scp=85143728400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85143728400&partnerID=8YFLogxK

U2 - 10.1097/OGX.0000000000001113

DO - 10.1097/OGX.0000000000001113

M3 - Comment/debate

AN - SCOPUS:85143728400

SN - 0029-7828

VL - 77

SP - 741

EP - 742

JO - Obstetrical and Gynecological Survey

JF - Obstetrical and Gynecological Survey

IS - 12

ER -

Linzagolix With and Without Hormonal Add-Back Therapy for the Treatment of Symptomatic Uterine Fibroids: Two Randomized, Placebo-Controlled, Phase 3 Trials

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this